Annual income statement for Genetec, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,683 | 5,864 | 7,148 | 8,125 | 10,983 |
| Cost of Revenue | |||||
| Gross Profit | 1,962 | 2,318 | 2,909 | 3,271 | 4,148 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,631 | 5,782 | 6,525 | 7,452 | 10,166 |
| Operating Profit | 52.6 | 82.2 | 623 | 672 | 817 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 117 | 87.9 | 630 | 662 | 827 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 56.6 | 23.8 | 415 | 421 | 510 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 56.6 | 23.8 | 415 | 421 | 510 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 56.6 | 23.8 | 415 | 421 | 510 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 10.8 | 6.74 | 43 | 45.8 | 55.4 |
| Dividends per Share | |||||
| Special Dividends per Share |